Breast Fat Grafting After Cancer / Lipomodelling | Results and ongoing cancer follow-up

Fat grafting to the breast often needs repeating because only part of the transferred fat survives; reported take rates range from 50% to 80%. In one retrospective review of 110 patients with contour deformities in reconstructed breasts, 55% needed more than one session. More sessions may be expected in hostile environments such as irradiated fields. Because swelling can obscure early results and grafted fat usually stabilizes by about three months, careful assessment before then may be misleading. Regular imaging and surgeon follow-up help distinguish normal post-graft changes from recurrence, especially after cancer. Only patients free of local breast disease are considered eligible, with clinical and radiological breast evaluation.

Breast fat grafting after cancer treatment is used to correct contour deformities and step-offs after reconstruction, and sometimes to improve lumpectomy defects. The transferred fat is living tissue that must gain blood supply from the recipient site, so some volume is lost naturally and several sessions may be needed. Significant weight gain or loss can also change grafted fat volume. Only patients free of local breast disease are considered eligible, with appropriate clinical and radiological evaluation. Gradual volume loss after grafting is common and unpredictable, so surgeons avoid excessive overcorrection. Viability depends on harvesting, processing and delivery technique, and donor-site choice follows patient and surgeon preference, including the abdomen, flanks or thighs.

The transferred fat follows the same course as your other body fat: it can increase with weight gain and decrease with weight loss. Grafted fat also resorbs at variable rates, so asymmetry can develop or change over time. Because each breast may start with a different volume and receive a different amount of grafted fat, weight change can affect them differently. Grafted fat must gain blood supply from the breast area, so some survives and some does not, which also affects symmetry. Several fat-grafting sessions may be needed to achieve desired results. This is a possibility, not a certainty, and the degree depends on your body and original reconstruction.

Fat grafting after cancer is used for contour defects, and imaging changes can occur. Both patients with and without prior breast cancer need routine imaging surveillance throughout life. Concerning findings may warrant additional imaging. One source describes obtaining preoperative mammogram and photographs, plus postoperative mammogram and photographs one year after surgery, with follow-up per ACS guidelines. Before surgery, family history of breast cancer and history of breast surgery or procedures should be asked. Only patients free of local breast disease are considered eligible, with appropriate clinical and radiological breast evaluation. Sharing your surgical history and prior imaging helps distinguish expected post-graft changes from suspicious lesions and reduces unnecessary biopsies.

For sequelae after breast-conserving treatment, coincidence risk with new cancer or recurrence is high, so strict control is needed. The protocol includes complete breast imaging with mammography, ultrasound and MRI by a skilled radiologist, and radiologist and oncologist agreement is generally required before lipomodelling. Imaging is repeated one year after the procedure, with microbiopsy if doubt remains. Imaging quality is not affected and fat grafts do not impair detection when rules are followed and imaging is done by a skilled radiologist. Consensus says fat grafting alone does not increase recurrence or reduce detection, though more studies are needed after breast-conserving therapy or reconstruction. Eligibility also requires being free of local breast disease and appropriate clinical and radiological evaluation.

Radiation can cause fibrosis in subcutaneous tissue, which hinders smooth expansion as volume increases. Patients with prior radiation are especially prone to needing more than one fat-grafting procedure because the soft-tissue envelope is less compliant, with postulated higher fat resorption than in patients without radiation. After adjuvant radiotherapy, about four additional sittings may be needed to address radio damage, and the whole process may extend up to three years. Several sessions may be necessary, especially after radiation, because grafted fat must acquire vascularity from the recipient site. This is a tissue-quality issue, not proof that fat grafting increases cancer recurrence.

Radiation causes fibrosis, swelling and poor blood supply, so irradiated tissue is stiff and less able to accept grafted fat. Fat is injected in small amounts per session; fibrosis limits volume, and the number of procedures relates to severity of damage. Evidence describes improvement in mastectomy flap quality, skin texture, contour and even sensation after repeated grafting, and fat grafting may help healing before revision surgery. It is not a single quick fix; some fat survives and some does not, so expectations should be modest and individualized. Multiple sessions are often needed, especially after radiation. Improvement may include softer skin and better contour over time.

Fat necrosis after breast fat grafting can appear as a palpable lump, oil cyst, hardening or calcification, and may cause pain on palpation. It can be alarming because it may resemble a tumor, but calcifications from surgery usually look benign and can often be distinguished from malignant patterns. A palpable mass should be assessed with breast imaging to rule out malignancy, and biopsy is recommended if findings are indeterminate. Superficial oily cysts may be aspirated with a needle. Harder fibrotic or calcified areas may need different management. Because fat necrosis can be cystic, fibrotic or calcified, the right approach depends on imaging findings and symptoms. Prompt assessment matters after cancer treatment.

Fat grafting is often an adjunct, not the only reconstructive method after cancer treatment. It may correct contour deformities, improve radiated tissue quality, add volume to a flap, or camouflage implant rippling. Several sessions may be necessary, especially after radiation; up to 55% of patients need more than one session. Surgeons can choose implant-based or autologous tissue reconstruction tailored to each patient. Total breast reconstruction with fat alone usually requires consecutive sessions and is selected for suitable patients. Fat survival also depends on recipient site properties, age, smoking and comorbidities, and no universal technique consensus exists. Careful patient selection and follow-up remain important because graft survival varies between individuals.

Fat grafting can smooth contour deformities after cancer treatment, but it may create expected imaging changes such as oil cysts or calcifications. These are usually benign and look different from suspicious cancer-related calcifications; if doubt remains, ultrasound, MRI or fine-needle biopsy can clarify. Fat grafting in the subcutaneous layer does not interfere with breast examination or cancer follow-up. Published clinical studies in more than 2,000 patients have not reported increased recurrence or detection difficulties, although laboratory concerns remain unresolved. Surgeons should remain vigilant and judicious to identify recurrence, differentiate expected benign post-grafting lesions, and treat expeditiously. Routine imaging surveillance remains essential for both groups. Any concerning physical-exam findings may warrant additional imaging.